Bionomics

is an Australia-based biotechnology firm that develops and researches ion channel targeting drug candidates for the treatment of central nervous system disorders...
Read more
Bionomics President & CEO: Spyros Papapetropoulos

President & CEO

Spyros Papapetropoulos

CEO Approval Rating

82/100

Annual Revenue
$15.6M
Employees
7
Funding
$44.9M
Acquisitions
1

Bionomics Competitors

1GSK
2Pfizer
3Vistagen
4Vanda
5Jazz Pharmaceuticals
6Aptinyx
7Otsuka Pharmaceutical
8Lundbeck
9Acadia
10BioXcel Therapeutics

Trending Companies